Webb14 mars 2024 · Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on …
Prothena Corporation plc - Prothena to Participate in JMP …
Webb8 feb. 2024 · Pipeline and potential catalysts. Prothena is a Dublin-based biotech company with several interesting drug candidates in its pipeline, as listed below. Prothena seems … Webb13 apr. 2024 · Prothena Corporation plc is a late-stage clinical biotechnology company with expertise in protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare peripheral amyloid diseases. christine bouthier notaire
Prothena (PRTA) Riding High on Alzheimer
Webb31 mars 2024 · DUBLIN, March 31, 2024--(BUSINESS WIRE)--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced new preclinical data from its PRX012 program, a potential best-in-class anti-amyloid beta … Webb12 juli 2024 · Prothena Corporation plc is a late-stage clinical company with a robust pipeline of novel investigational therapeutics built on protein dysregulation expertise … Webb21 mars 2024 · 21.03.2024 - Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics … christine bouchery